NUTM2A and breast cancer: To explore whether NUTM2A-AS1 may influence the long-term survivals of BC patients, we searched “GEPIA” and found that high NUTM2A-AS1 levels were involved in the OS of BC patients based on TCGA datasets (Figure 1(a)).